Filed before 2025Filed 6 January 2022
Eikon Therapeutics, Inc. raised $518M
Eikon Therapeutics, Inc., a biotech company based in Hayward, CA, raised $518M in a new equity round, according to a filing dated 6 January 2022.
Raises filed before 2025 are not checked for a public announcement.
- Filed
- 6 January 2022
- Round
- Equity round
- Amount sold
- $518M
- Offering size
- $525M
- Investors so far
- 43
- Based in
- Hayward, CA
- Website
- eikontx.com
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
4 directors of this company are named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 100% of the 1,764 tracked raises with an amount filed in 2022, and than 100% of the 142 in biotech.
Eikon Therapeutics, Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 28 Feb 2025 | New filing | $351M | Another raise |
| 1 Jun 2023 | New filing | $141M | Another raise |
| 6 Jan 2022 | New filing | $518M | This raise |
| 13 May 2021 | New filing | $103M | Another raise |
More with Foresite Capital on the board
- Alumis Inc.$129M
- Interline Therapeutics, Inc.$50M
- FL2020-004, Inc.$1.5K
- Pardes Biosciences, Inc$51.6M
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.